New York, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) ...

A new systematic review of 17 clinical trials found that drugs targeting amyloid beta proteins, a biomarker of Alzheimer's disease, are likely to have no clinically meaningful effects. The study was ...

The wiping of unwanted memories is a common staple of science-fiction and if you believe this weekend's headlines, you might think that the prospect has just become a reality. The Press Association ...

A little blue pill is creating a stir in Hollywood—and no, it's not Viagra. It's propranolol, a beta blocker originally designed for heart conditions, that's now making its way into dressing rooms, ...

A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa Health Care researchers. Using clinical information from a large, ...

Orphan drug designation incentives have helped boost enthusiasm for researching and developing drugs for beta thalassemia, a new review concludes. The review encompassed all beta-thalassemia drugs ...

Following recent FDA approval of Biogen's Alzheimer antibody drug ADUHELM (TM), targeting oligomers of amyloid beta, Galimedix aims for first patients with its GAL-201 oral small molecule drug within ...